Marfan Syndrome: Clinical Trials

9 trials for Marfan Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 terminated, 1 withdrawn. 9 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 39Completed 5, Unknown 2, Terminated 1, Withdrawn 1

Follow Marfan Syndrome: new trials by email Literature Review of Marfan Syndrome trials Research Report on Marfan Syndrome

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome
Blood draw - Marfan Syndrome
Phase 3WithdrawnAnn & Robert H Lurie Children's Hospital of Chicago2011-04-012016-02-05
Comparison of Aliskiren vs Negative Controls on Aortic Stiffness in Patients With MFS
Aliskiren, Atenolol - Marfan Syndrome
Phase 3CompletedSamsung Medical Center302010-06-012017-06-05
Randomized, Double-blind Study for the Evaluation of the Effect of Losartan Versus Placebo on Aortic Root Dilatation in Patients With Marfan Syndrome Under Treatment With Beta-blockers
Losartan, Placebo - Marfan Syndrome
Phase 3CompletedUniversity Hospital, Ghent222009-11-012022-12-22
Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome
Losartan, Atenolol - Marfan Syndrome
Phase 3UnknownForteza, Albert, M.D.1402008-10-012010-08-12
Study of the Efficacy of Losartan on Aortic Dilatation in Patients With Marfan Syndrome
placebo, Losartan - Marfan Syndrome
Phase 3TerminatedAssistance Publique - Hôpitaux de Paris3032008-09-012015-11-04
Nebivolol Versus Losartan Versus Nebivolol+Losartan Against Aortic Root Dilation in Genotyped Marfan Patients
Losartan and nebivolol, Losartan, Nebivolol - Marfan Syndrome
Phase 3UnknownFondazione IRCCS Policlinico San Matteo di Pavia2912008-07-012011-07-22
Effects of Losartan Versus Atenolol on Aortic and Cardiac Muscle Stiffness in Adults With Marfan Syndrome
Atenolol, Losartan - Marfan Syndrome
Phase 3CompletedBrigham and Women's Hospital402007-10-012014-09-09
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome
Losartan Potassium, Atenolol - Marfan Syndrome
Phase 3CompletedCarelon Research6082007-01-012025-03-07
Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Coversyl (perindopril) - Marfan Syndrome
Phase 3CompletedBayside Health172004-01-012007-06-13

Narrower conditions

Aortic Aneurysm, Thoracic (1)  ·  Camurati-Engelmann Syndrome (1)  ·  Dissection, Ascending Aorta (1)

Broader conditions

Abnormalities, Multiple (9)  ·  Bone Diseases (9)  ·  Bone Diseases, Developmental (9)  ·  Cardiovascular Abnormalities (9)  ·  Cardiovascular Diseases (9)  ·  Congenital Abnormalities (9)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Connective Tissue Diseases (9)  ·  Genetic Diseases, Inborn (9)  ·  Heart Defects, Congenital (9)  ·  Heart Diseases (9)  ·  Musculoskeletal Diseases (9)  ·  Skin and Connective Tissue Diseases (9)  ·  Aneurysm (2)  ·  Aortic Diseases (2)

Interventions

Losartan (6)  ·  Atenolol (4)  ·  Blood Specimen Collection (1)  ·  Nebivolol (1)  ·  Perindopril (1)  ·  aliskiren (1)

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bayside Health (1)  ·  Brigham and Women's Hospital (1)  ·  Carelon Research (1)  ·  Fondazione IRCCS Policlinico San Matteo di Pavia (1)  ·  Forteza, Albert, M.D. (1)  ·  Samsung Medical Center (1)  ·  University Hospital, Ghent (1)

Countries

United States (3)  ·  Belgium (2)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Alberto Forteza, Dr (1)  ·  Arturo Evangelista, Dr (1)  ·  Bronwyn A Kingwell, PhD (1)  ·  Duk-Kyung Kim, PhD MD (1)  ·  Eloisa Arbustini, MD,FESC,FACC (1)  ·  Julie De Backer, MD, PhD (1)  ·  Luigi Tavazzi, MD,FESC,FACC (1)  ·  Mark A Creager, MD (1)  ·  Ron Lacro, MD (1)

Results publications

PMID 17911499, PMID 16601194, PMID 17188619, PMID 19430350, PMID 20619242, PMID 23622922, PMID 25405392, PMID 25935877, PMID 26052700, PMID 29948025

NIH funding

U01HL068270 (1)